NOVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 1.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Novan Insider Trading History Chart

Novan Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 07/26/2023 12:59 AM ET

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

Novan Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/27/2023	Machelle Sanders	Director	Sell	11,553	$0.41	$4,736.73	25,248
4/7/2022	James L Bierman	Director	Buy	1,000	$3.45	$3,450.00	4,000
3/28/2022	James L Bierman	Director	Buy	1,000	$3.45	$3,450.00
3/25/2022	James L Bierman	Director	Buy	2,000	$3.54	$7,080.00
3/18/2022	John M Gay	CFO	Buy	1,000	$3.50	$3,500.00
3/18/2022	John W Palmour	Director	Buy	10,000	$3.63	$36,300.00
3/16/2022	John W Palmour	Director	Buy	5,000	$3.34	$16,700.00

Video: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You

From Brownstone Research | Ad

“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up to a location just a few miles from here to show you Elon Musk’s next AI product. I promise what happens next will shock you…”

Click here to see what happened

SEC Filings (Institutional Ownership Changes) for Novan (NASDAQ:NOVN)

14.51% of Novan stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Novan Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2023	Oak Harbor Wealth Partners LLC	27,166	$35K	0.0%	-48.1%	0.097%
3/15/2023	B. Riley Wealth Advisors Inc.	155,000	$0.23M	0.0%	+76.5%	0.728%
11/14/2022	Armistice Capital LLC	2,293,000	$4.29M	0.1%	+75.4%	10.774%
11/7/2022	Forum Financial Management LP	15,000	$28K	0.0%	N/A	0.070%
9/9/2022	B. Riley Wealth Management Inc.	79,150	$0.18M	0.0%	+32.7%	0.372%
5/11/2022	Oak Harbor Wealth Partners LLC	52,366	$0.21M	0.1%	+61.8%	0.273%
5/11/2022	GSA Capital Partners LLP	127,121	$0.50M	0.1%	N/A	0.664%
5/10/2022	B. Riley Wealth Management Inc.	59,650	$0.24M	0.0%	+79.9%	0.312%
5/10/2022	First Horizon Advisors Inc.	15,069	$59K	0.0%	N/A	0.079%
5/3/2022	Leo Brokerage LLC	66,435	$0.26M	0.0%	N/A	0.347%
2/10/2022	B. Riley Wealth Management Inc.	33,150	$0.14M	0.0%	+50.7%	0.176%
11/15/2021	GSA Capital Partners LLP	89,211	$0.73M	0.1%	+557.7%	0.474%
11/12/2021	Geode Capital Management LLC	134,684	$1.10M	0.0%	+9.5%	0.716%
11/12/2021	B. Riley Wealth Management Inc.	22,000	$0.18M	0.0%	+14.8%	0.117%
11/9/2021	BlackRock Inc.	303,017	$2.47M	0.0%	-26.9%	1.611%
9/17/2021	Virtu Financial LLC	46,108	$0.46M	0.0%	N/A	0.245%
8/25/2021	Marshall Wace LLP	231,154	$2.33M	0.0%	N/A	1.229%
8/25/2021	Marshall Wace North America L.P.	292,710	$2.95M	0.0%	N/A	1.556%
8/17/2021	Walleye Capital LLC	103,513	$1.04M	0.0%	N/A	0.550%
8/17/2021	Bridgeway Capital Management LLC	35,000	$0.35M	0.0%	-92.5%	0.186%
8/16/2021	Squarepoint Ops LLC	17,775	$0.18M	0.0%	-88.6%	0.095%
8/16/2021	Alyeska Investment Group L.P.	41,652	$0.42M	0.0%	N/A	0.221%
8/16/2021	State Street Corp	60,876	$0.61M	0.0%	-5.6%	0.324%
8/16/2021	Sabby Management LLC	19,132	$0.19M	0.0%	N/A	0.102%
8/16/2021	Marshall Wace LLP	231,154	$2.33M	0.0%	N/A	1.229%
8/13/2021	Northern Trust Corp	27,867	$0.28M	0.0%	-90.7%	0.148%
8/13/2021	Laurion Capital Management LP	66,654	$0.67M	0.0%	N/A	0.354%
8/13/2021	Liberty Wealth Management LLC	4,779	$0.48M	0.0%	N/A	0.025%
8/13/2021	Geode Capital Management LLC	122,963	$1.24M	0.0%	-89.6%	0.654%
8/13/2021	Vanguard Group Inc.	781,772	$7.86M	0.0%	-86.9%	4.157%
8/12/2021	Monashee Investment Management LLC	375,000	$3.77M	0.5%	N/A	1.994%
8/12/2021	B. Riley Wealth Management Inc.	19,157	$0.19M	0.0%	N/A	0.102%
8/11/2021	Edmond DE Rothschild Holding S.A.	10,000	$0.10M	0.0%	-90.0%	0.053%
8/11/2021	BlackRock Inc.	414,458	$4.17M	0.0%	-84.4%	2.204%
8/10/2021	Principal Financial Group Inc.	68,883	$0.69M	0.0%	N/A	0.366%
8/5/2021	GSA Capital Partners LLP	13,565	$0.14M	0.0%	N/A	0.072%
5/19/2021	Squarepoint Ops LLC	155,497	$0.24M	0.0%	N/A	0.102%
5/18/2021	Millennium Management LLC	1,106,159	$1.73M	0.0%	N/A	0.729%
5/18/2021	Cubist Systematic Strategies LLC	63,010	$98K	0.0%	N/A	0.042%
5/18/2021	Citadel Advisors LLC	196,189	$0.31M	0.0%	N/A	0.129%
5/17/2021	Edmond DE Rothschild Holding S.A.	100,000	$0.16M	0.0%	N/A	0.066%
5/17/2021	Price T Rowe Associates Inc. MD	77,800	$0.12M	0.0%	N/A	0.051%
5/13/2021	Renaissance Technologies LLC	1,826,044	$2.85M	0.0%	N/A	1.204%
5/13/2021	Bank of New York Mellon Corp	68,276	$0.11M	0.0%	N/A	0.045%
5/12/2021	Northern Trust Corp	300,561	$0.47M	0.0%	+5.7%	0.198%
5/12/2021	Geode Capital Management LLC	1,183,989	$1.85M	0.0%	+18.9%	0.781%
5/7/2021	BlackRock Inc.	2,662,565	$4.15M	0.0%	-22.5%	1.756%
5/5/2021	Lakeview Capital Partners LLC	22,221	$35K	0.0%	N/A	0.015%
2/16/2021	Captrust Financial Advisors	112,347	$91K	0.0%	N/A	0.079%
2/12/2021	Prospera Financial Services Inc	38,611	$31K	0.0%	-61.7%	0.027%
2/11/2021	Northern Trust Corp	284,288	$0.23M	0.0%	+95.6%	0.201%
2/10/2021	HighTower Advisors LLC	48,500	$39K	0.0%	N/A	0.034%
2/5/2021	BlackRock Inc.	3,434,770	$2.79M	0.0%	+18,771.3%	2.427%
12/11/2020	Virtu Financial LLC	68,602	$33K	0.0%	N/A	0.048%
11/13/2020	Morgan Stanley	219,607	$0.11M	0.0%	N/A	0.155%
11/12/2020	JPMorgan Chase & Co.	53,000	$26K	0.0%	N/A	0.037%

Data available starting January 2016

Novan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

7,190,000 shs

Average Volume

602,421 shs

Market Capitalization

$2.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Novan?: Novan's top insider investors include:
Machelle Sanders (Director)
Learn More about top insider investors at Novan.